Companies / BOC Sciences / Clenoliximab
BOC Sciences

Clenoliximab | BOC Sciences

Clenoliximab is a chimeric monoclonal antibody directed against CD4. Clenoliximab acts as an immunomodulator with the potential for the treatment of rheumatoid arthritis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.